New York, Oct. 25, 2017 -- According to a recent market report published by Persistence Market Research titled “Clinical Communication and Collaboration Market: Global Industry Analysis (2012–2016) and Forecast (2017–2025),” revenue from the global clinical communication and collaboration market was US$ 138.5 Mn in 2012 and US$ 214.8 Mn in 2016, representing a CAGR of 11.6% from 2012 to 2016. This revenue growth is attributed to addition of new features in clinical communication and collaboration solutions. Persistence Market Research forecasts revenue from the global clinical communication and collaboration market to increase from US$ 249.4 Mn in 2017 to US$ 861.6 Mn by 2025 end, representing a CAGR of 16.9% from 2017 to 2025. This increasing revenue growth is attributed to continuous launch of new clinical communication and collaboration solutions and option for customization supporting growth of this market.
Advancement in patient monitoring technologies and need for seamless communication among hospital staff are major factors driving revenue growth of the global clinical communication and collaboration market. However high initial costs and disruption of workflows are restraining revenue growth of the clinical communication and collaboration market.
Request a PDF Sample at https://www.persistencemarketresearch.com/samples/13042
Global Clinical Communication and Collaboration Market: Segmentation & Forecast
The global clinical communication and collaboration market is categorized on the basis of Component (Software, Services), Content Type (Text, Voice, Video), end user (Clinical Laboratories, Hospitals, Physicians, Others), and Region (North America, Latin America, Europe, Asia Pacific and Middle East and Africa).
- By component, revenue generation from the Services segment is expected to increase at a high CAGR of 19.1% over the forecast period. In terms of value, the Services segment is anticipated to increase 3.9X between 2017 and 2025. The Services segment is expected to register high Y-o-Y growth rates throughout the forecast period. In terms of value, the Software segment is projected to be the most attractive in the global clinical communication and collaboration market during the forecast period.
- By content type, the Video segment is expected to register high Y-o-Y growth rates throughout the forecast period. In terms of value, this segment is expected to expand at a CAGR of 18.4% during the forecast period. In terms of value, the Text segment is projected to be the most attractive in the global clinical communication and collaboration market during the forecast period.
- By end user, the Hospitals segment is projected to be the most attractive segment in terms of value in the global clinical communication and collaboration market during the forecast period. The Physicians segment is expected to register high Y-o-Y growth rates throughout the forecast period. In terms of value, this segment is expected to expand at a CAGR of 17.2% during the forecast period.
- By region, the Asia Pacific regional market is expected to register high Y-o-Y growth rates throughout the forecast period. In terms of value, APAC is expected to expand at a CAGR of 18.8% during the forecast period. In terms of value, the APAC market is anticipated to increase 3.8X between 2017 and 2025. Clinical communication and collaboration solution providers can focus on expanding across several countries in APAC region such as India, China.
View Report Table of Contents, Figures, and Tables
Vendor Insights
The report profiles some of the leading companies operating in the global clinical communication and collaboration market such as VOCERA COMMUNICATIONS, INC., TIGERTEXT, Cisco Systems Inc., and Jive Software, Inc.
Popular Reports by Persistence Market Research:
- Global Market Study on Consumer Mobile Payments: https://www.persistencemarketresearch.com/market-research/consumer-mobile-payments-market.asp
- Enterprise Social Networks and Online Communities Market: https://www.persistencemarketresearch.com/market-research/enterprise-social-networks-and-online-communities-market.asp
Persistence Market Research Overview
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research U.S. Sales Office: 305 Broadway, 7th Floor New York City, NY 10007 +1-646-568-7751 United States USA - Canada Toll-Free: 800-961-0353 Email: [email protected]


SK Hynix Shares Hit Record High as AI Memory Demand Fuels Semiconductor Rally
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S.
Ford Targets Level 3 Autonomous Driving by 2028 with New EV Platform and AI Innovations
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S.
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue
xAI Cash Burn Highlights the High Cost of Competing in Generative AI
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid 



